Buy Tesamorelin Peptide | Growth Hormone Secretagogue
PotentPeptide
Back to Buy Peptides
Growth Hormone Secretagogue

Tesamorelin

Growth Hormone Releasing Hormone Analogue

The targeted solution for reducing stubborn visceral fat.

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone (GHRH). It is specifically engineered to stimulate the pituitary gland to produce and release the body's own growth hormone. It is most recognized for its FDA-approved application in reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy.

Tesamorelin research artwork
Growth Hormone Secretagogue

Read the research profile for mechanisms, citations, and safety context before comparing vendors. View the Tesamorelin research profile.

99%+ Purity
COA Included
Same-Day Dispatch

Key Benefits

Significantly reduces visceral adipose tissue (VAT)
Improves overall body composition
Increases endogenous Growth Hormone (GH) levels naturally
Boosts Insulin-like Growth Factor 1 (IGF-1) levels
May improve cognitive function in older adults and those with MCI
Can lower triglyceride levels
Enhances lipolysis for targeted fat breakdown
Minimal impact on blood glucose and insulin sensitivity

Mechanism of Action

Tesamorelin binds to and stimulates GHRH receptors on somatotroph cells in the anterior pituitary gland. This action triggers the synthesis and pulsatile release of endogenous growth hormone (GH). The subsequent increase in circulating GH leads to higher levels of Insulin-like Growth Factor 1 (IGF-1) from the liver, which mediates many of its metabolic effects, including enhanced lipolysis (fat breakdown).

Dosing Guidelines

Typical Dose

1-2 mg

Frequency

1x daily

Duration

12-26 weeks

Note: Administer subcutaneously in the evening before bed to mimic the body's natural GH pulse. It is best to inject on an empty stomach, at least 2 hours after the last meal.

Research & Studies

A comprehensive overview of Tesamorelin's mechanism, benefits, dosing, and research for visceral fat reduction.

Read Full Research

Pivotal clinical trials demonstrating Tesamorelin's efficacy and safety for treating lipodystrophy.

Read Full Research

Research exploring the potential neurocognitive benefits of GHRH analogues like Tesamorelin in aging populations.

Read Full Research

Potential Side Effects

Reported side effects may include:

  • - Injection site reactions (redness, itching, pain) - common
  • - Arthralgia (joint pain) - common
  • - Peripheral edema (mild fluid retention) - less common
  • - Myalgia (muscle aches) - less common
  • - Numbness or tingling in extremities (paresthesia)
  • - Requires monitoring of IGF-1 levels on long cycles

This information is for research purposes only. Always consult with a healthcare professional.

Popular Stacking Options

Tesamorelin + Ipamorelin

Ipamorelin is a GHRP that works synergistically with Tesamorelin (a GHRH) to create a powerful, pulsatile release of growth hormone from the pituitary, amplifying fat loss and recovery benefits.

Shop this stack

Tesamorelin + AOD-9604

Combines Tesamorelin's GH-mediated lipolysis with AOD-9604's direct fat-burning mechanism, creating a focused stack for accelerated fat loss without significant systemic effects.

Shop this stack

Frequently Asked Questions

How is Tesamorelin different from CJC-1295?

Tesamorelin is a GHRH analogue with a shorter half-life, promoting a more natural, pulsatile GH release that mimics the body's rhythm. CJC-1295 with DAC provides a constant, sustained elevation of GH levels, which can lead to receptor desensitization over time. Tesamorelin's action is considered more biomimetic and targeted.

Is Tesamorelin only for HIV patients?

While its FDA approval is for HIV-associated lipodystrophy, researchers are actively studying it for general visceral fat reduction, improved body composition, and cognitive benefits in non-HIV populations. Its targeted effect on visceral fat makes it a subject of interest for broader metabolic health applications.

Will Tesamorelin cause 'GH gut'?

'GH gut,' or visceral organ growth, is a risk associated with very high, long-term abuse of exogenous human growth hormone (HGH). Because Tesamorelin stimulates the body's own pulsatile release of GH, it is far less likely to cause this side effect, especially when used within recommended research protocols.

How long does it take to see results from Tesamorelin?

Significant reductions in visceral fat are typically measurable via imaging after about 12-26 weeks of consistent use. Subjective effects like improved energy or sleep quality might be noticed sooner, but the primary body composition changes require a longer duration protocol.

More from this category

Compare nearby options in the same category before choosing a research product.

Growth Hormone Secretagogue

CJC-1295

The long-acting GHRH for sustained growth hormone release and systemic benefits.

Growth Hormone Secretagogue

GHRP-2

A potent secretagogue for maximizing growth hormone release and lean mass.

Growth Hormone Secretagogue

GHRP-6

A potent ghrelin mimetic that triggers a strong pulse of growth hormone and stimulates appetite.

Growth Hormone Secretagogue

Hexarelin

The most potent synthetic GH secretagogue with unique cardioprotective benefits.

You might also like

These peptides share research keywords or protocol overlap with Tesamorelin.

Growth Hormone Secretagogue

Ipamorelin

Selective growth hormone release without the side effects

Growth Hormone Secretagogue

Sermorelin

Stimulate your body's natural growth hormone production for anti-aging and vitality.

Ready to Purchase Tesamorelin?

Get pharmaceutical-grade Tesamorelin from Simple Peptide with 99%+ purity, third-party lab testing, and same-day dispatch.

Buy Tesamorelin Now